Rechovot, Israel

Anat Reizelman


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Innovations of Inventor Anat Reizelman

Introduction:

Anat Reizelman, a talented inventor based in Rechovot, Israel, has made significant contributions to the field of pharmaceuticals with her innovative research. With one granted patent to her name, she focuses on developing novel compounds that hold the potential to transform treatments for various diseases.

Latest Patents:

Anat's patent, titled "Rigidified Compounds for Modulating Heparanase Activity," introduces unique rigidified compounds characterized by a rhodanine-like residue and at least one aryl or heteroaryl residue. These compounds are designed to have a core structure with one or zero free-to-rotate bonds. Furthermore, her invention includes pharmaceutical compositions that utilize these rigidified compounds to modulate the activity of heparanase, addressing heparanase-associated diseases and disorders. The compounds also have applications in modulating heparin-binding proteins and treating related medical conditions.

Career Highlights:

Anat Reizelman currently works at Insight Biopharmaceuticals Ltd., where she contributes her expertise in pharmaceutical innovation. Her background and dedication to her work have allowed her to play a key role in advancing therapeutic solutions that target complex medical conditions.

Collaborations:

Anat collaborates with respected coworkers, including Joel M Van Gelder and Joseph Y Klein, which highlights the collaborative spirit that drives innovation in her field. Working alongside these professionals enables her to develop and refine her groundbreaking research.

Conclusion:

Anat Reizelman is an inspiring figure in the world of inventors, exemplifying the power of innovation in addressing health challenges. Her patent for rigidified compounds demonstrates her commitment to improving treatment options for patients and the ongoing effort to combat disease through scientific advancement. As she continues her work at Insight Biopharmaceuticals Ltd., it is clear that her contributions will have a lasting impact on the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…